Date: December 1, 2025

Executive Summary

An international team led by the University of Leipzig identified variants in the GRIN2A gene that alone can cause mental illness, challenging the view that psychiatric disorders are strictly polygenic. Some patients with these variants develop early‑onset psychiatric symptoms without seizures or learning problems, and early treatment with the amino acid L‑serine shows promise. This breakthrough paves the way for precision psychiatry and targeted therapies.

Full Article

Nearly one in seven people globally live with a mental illness, and genetics has long been recognized as one risk factor. Until now, psychiatric disorders were thought to result from complex interactions among many genes. Researchers at Universität Leipzig and collaborating institutions overturned this assumption by showing that specific variants of the GRIN2A gene can, on their own, trigger mental illness. In a cohort of 121 individuals carrying the mutation, the team found that psychiatric symptoms often emerged in childhood or adolescence rather than adulthood.

GRIN2A encodes a subunit of the NMDA receptor, which regulates electrical signaling between neurons. Mutations that reduce receptor function disrupt neural communication and lead to disorders such as schizophrenia and other psychiatric illnesses. Intriguingly, some patients in the study showed only psychiatric symptoms without the seizures or intellectual disabilities typically associated with GRIN2A mutations. Early treatment with L‑serine, a supplement that enhances NMDA receptor activity, led to noticeable improvements in some individuals.

For entrepreneurs in biotech and digital health, this discovery signals a shift toward precision psychiatry. Genetic testing services could identify individuals with high‑risk variants, enabling early intervention. Startups may develop targeted therapies that modulate NMDA receptor activity or gene‑editing approaches to correct harmful variants. Combined with AI‑driven diagnostics and personalized care plans, gene‑focused mental‑health solutions could revolutionize treatment while opening new markets.

Subscribe to our Newsletter to stay up to date with the latest breakthroughs in AI, Business, Technology, and Mindset.